Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

Miller, C. N., Althoff, K. N., Schlueter, D. J., Anton-Culver, H., Chen, Q., Garbett, S., Ratsimbazafy, F., Thomsen, I., Karlson, E. W., Cicek, M., Pinto, L. A., Malin, B. A., Ohno-Machado, L., Williams, C., Goldstein, D., Kouame, A., Ramirez, A., Gebo, K. A., & Schully, S. D. (2022). Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence. MSphere, 7(5). https://doi.org/10.1128/msphere.00257-22
Authors:
Cheryl N Miller
Keri N Althoff
David J Schlueter
Hoda Anton-Culver
Qingxia Chen
Shawn Garbett
Francis Ratsimbazafy
Isaac Thomsen
Elizabeth W Karlson
Mine Cicek
Ligia A Pinto
Bradley A Malin
Lucila Ohno-Machado
Carolyn Williams
David Goldstein
Aymone Kouame
Andrea Ramirez
Kelly A Gebo
Sheri D Schully
Affiliated Authors:
David Goldstein
Author Keywords:
sars-cov-2
igg antibodies
spike protein
nucleocapsid protein
low prevalence
Publication Type:
Article
Unique ID:
10.1128/msphere.00257-22
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: